BioInvent International
23.10 SEK
+3.82 %
Less than 1K followers
BINV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.8 | 21.4 | 44.7 | 22.1 | 198.1 | 3.3 | 3.0 | 226.5 |
| EBITDA | -102.3 | -121.0 | -451.8 | -117.7 | 34.1 | -128.8 | -119.5 | -331.8 |
| EBIT | -107.2 | -125.9 | -471.1 | -122.8 | 34.1 | -133.6 | -129.4 | -351.7 |
| EBIT-% | -839.7 % | -589.0 % | -1,054.1 % | -556.6 % | 17.2 % | -4,023.1 % | -4,285.1 % | -155.3 % |
| Profit before taxes | -97.2 | -116.8 | -429.2 | -116.6 | 38.9 | -129.1 | -125.6 | -332.5 |
| Net income | -97.2 | -116.9 | -429.4 | -116.6 | 38.8 | -129.2 | -125.8 | -332.9 |